Dementia   

Would you consider benzodiazepines for agitation in progressive supranuclear palsy? What other treatment strategies would you consider? 

How do you counsel patients on this off-label use?

E.g., amyloid PET, CSF amyloid, blood-based amyloid.

Specifically, what guidelines do you use to help determine this (if any)? 

Related Q&A on antipsychotics in Alzheimer's.In light of the publication from Choma et al., PMID 41063545.

E.g., primary progressive aphasia